Google’s “Learn Your Way” is Set to Redefine Education and Challenge the AI “Dumbing Down” Narrative
Generative AI is often villainised as something that will dumb people down. But new tools from AI companies are doing just ...
The 5-Year Risk Score: New AI tools can analyze your current “normal” tissue to identify hidden biomarkers of future risk.
Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. When endocrinologist Mary Elizabeth Patti looks ...
Department of Anesthesiology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China Objective: While outcomes-based education (OBE) has been widely advocated for decades, its ...
Objective To investigate the effectiveness of cryotherapy on pain intensity, range of motion (ROM), swelling and function in the postoperative care of musculoskeletal disorders. Design Systematic ...
The FDA is raising the bar for approval of CAR T-cell therapies in oncology. Under plans outlined by the FDA’s biologics chief Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to ...
Objectives Prospective registration of randomised controlled trials (RCTs) is an international standard of good clinical practice but is often neglected by evidence synthesis producers. This study ...
Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook First seen in Marvel Comics in 1962’s The Incredible Hulk #3, Maynard Tiboldt took over the role ...
THANKS TO A CACHE OF DECLASSIFIED DOCUMENTS, the public is now well aware of the Central Intelligent Agency’s misadventures in mind control throughout the 1950s and 1960s. MKUltra—the agency’s ...
In Stranger Things, there are many references to things from other fictional worlds, specifically the land of Dungeons & Dragons. But, when the series began to expand the backstory of Eleven (aka Jane ...
Orforglipron, a small-molecule, nonpeptide oral glucagon-like peptide-1 (GLP-1) receptor agonist, is being investigated as a treatment for obesity. In this phase 3, multinational, randomized, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results